The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4,080 confirmed cases, 78% above all of 2025.
|Videos|March 3, 2020
Potential Complications from Flu
Author(s)Contagion® Editorial Staff
Jason Gallagher, PharmD, discusses the risk factors for experiencing complications of influenza.
Advertisement
Segment Description: Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, clinical professor at Temple University College of Pharmacy and editor-in-chief of Contagion®, discusses the risk factors for experiencing complications of influenza.
Transcript (modified slightly for readability):
Gallagher: Most years the mortality rate from influenza is a U shaped curve where the mortality is the highest in the very young and in elderly patients and that's due to immune response, but also comorbid diseases, particularly in the elderly. Comorbidities are really what people put people at the highest risk of complications from influenza. Asthma, COPD, other pulmonary conditions, even heart conditions, and the immunocompromised population, all of these patients are at a significantly higher risk of complications from influenza than the general population.
It's such a list that if you were to break it down before it was recommended to be given universally, if you just look at this special populations that the influenza vaccine was recommended for, it's so many people that it just makes more sense to vaccinate everyone anyway. While everybody should get a flu shot, people with those types of comorbidities are at the highest risk of complications, and it's essential that we vaccinate them.
Advertisement
Related to this article
UTI guidelines are moving away from complicated or uncomplicated infections to localized or systemic classification terminologies. Guidelines author Zachary Nelson, PharmD, MPH, BCIDP, provides further insights on the changes including applying antibiograms, potential costs, and whether clinicians will embrace these new classifications.
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate met every prespecified primary immunogenicity and safety endpoint against PCV20 and PCV21 in the OPUS-1 trial of 4,047 US adults.
Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
Lori Handy, MD, provides guidance in these areas, including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
Advertisement
Advertisement